PDGFRα- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features

被引:96
作者
Pauls, K
Merkelbach-Bruse, S
Thal, D
Büttner, R
Wardelmann, E
机构
[1] Univ Bonn, Sch Med, Dept Pathol, Med Ctr, D-53011 Bonn, Germany
[2] Univ Bonn, Med Ctr, Dept Neuropathol, D-53011 Bonn, Germany
关键词
GIST; Kit; PDGFR alpha;
D O I
10.1111/j.1365-2559.2005.02061.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To study the immunohistochemical and histological features of 158 gastrointestinal stromal tumours (GISTs), consisting of 137 tumours with mutations in c-kit and platelet-derived growth factor receptor-alpha (PDGFRalpha) genes and 21 wt-GISTs. Additionally, we evaluated the localization of PDGFRalpha in the normal intestine. PDGFRalpha gene mutations were recently described in a subset of GISTs and it has been hypothesized that PDGFRalpha-mutated tumours represent a distinctive entity among GISTs. Results: PDGFRalpha was expressed in ganglion bodies of the myenteric plexus and in Schwann cells but not in interstitial cells of Cajal. In contrast to other GISTs, tumours with PDGFRalpha mutations had an epithelioid phenotype and multinuclear giant cells. Kit was down-regulated in PDGFRalpha-mutated GISTs and PDGFRalpha expression was decreased in c-kit mutated tumours. Dot-like staining of Kit and PDGFRalpha was associated very frequently with mutation within the respective gene. Conclusions: Features of PDGFRalpha-mutated GISTs are multinuclear giant cells and dot-like staining for PDGFRalpha. In contrast, c-kit-mutated GISTs display a spindle cell phenotype and Kit-dots on immunohistochemistry. Our findings not only help to distinguish distinctive entities of GISTs using histological and immunhistochemical features, but also indicate that Kit and PDGFRalpha are differentially regulated in a subset of GISTs.
引用
收藏
页码:166 / 175
页数:10
相关论文
共 26 条
  • [21] Activating mutations in c-KIT and PDGFRα are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes
    Burger, H
    den Bakker, MA
    Kros, JM
    van Tol, H
    de Bruin, AM
    Oosterhuis, W
    van den Ingh, HFGM
    van der Harst, E
    de Schipper, HP
    Wiemer, EAC
    Nooter, K
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (11) : 1270 - 1274
  • [22] Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours
    Wang, Chao
    Jin, Mei-Shan
    Zou, Ya-Bin
    Gao, Jing-Na
    Li, Xiao-Bo
    Peng, Fang
    Wang, Hai-Ying
    Wu, Zhen-Dong
    Wang, Yin-Ping
    Duan, Xiu-Mei
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1055 - 1065
  • [23] THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
    Jianyi Sun
    Qiang Zhang
    Xiangfei Sun
    Anwei Xue
    Xiaodong Gao
    Kuntang Shen
    [J]. Cell Communication and Signaling, 20
  • [24] THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
    Sun, Jianyi
    Zhang, Qiang
    Sun, Xiangfei
    Xue, Anwei
    Gao, Xiaodong
    Shen, Kuntang
    [J]. CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [25] The GIST of targeted cancer therapy:: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)
    DeMatteo, RP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) : 831 - 839
  • [26] The GIST of targeted cancer therapy: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)
    Ronald P. DeMatteo
    [J]. Annals of Surgical Oncology, 2002, 9 : 831 - 839